Funding Opportunities

AAUW Educational Foundation Fellowships and Grants
Aging
Alcohol & Drugs
Alternative Medicine
Autoimmune/ Immune
Cancer
Clinical Research
Disabilities
Environmental
Gender-Specific
HIV / AIDS
Mental Health
Menopause
Musculoskeletal
Neurological
Obesity
Oral Health
Pain
Reproductive Health
Urinary
Violence

University of Cincinnati

TBA

Extramural Funding

Biobehavioral Research for Effective Sleep
Department of Health and Human Services (DHHS)
National Institutes of Health (NIH)
PA-00-046
Deadline:  October 01, 2002
Up to $250,000 per year
The goal of this program announcement (PA) is to stimulate clinical and applied research on behavioral, psychosocial, and physiological consequences of acute and chronic partial sleep deprivation in either chronically ill or healthy individuals and to develop environmental, clinical management, and other interventions with the potential to reduce sleep disturbances and significantly improve the health of large numbers of people. Although sleep disorders are a cause of sleep loss in affected individuals, the questions to be addressed under this solicitation should focus on causes and consequences of sleep deprivation, apart from any sleep pathology. 

Examples include:
- identify specific chronically ill populations at increased risk (e.g., Alzheimer's disease, rheumatoid arthritis, cardiopulmonary disease, cancer survivors, patients with alcohol problems) of chronic partial sleep deprivation and identify the etiology of excessive daytime sleepiness, apart from sleep disorders within these populations; 
- identify factors contributing to sleep deprivation (e.g., shift work, occupational demands, environmental conditions, alcohol and drug use, lifestyle choices, stress, medical treatment sequelae) and whether age, gender, and ethnicity may play a role; 
- determine the physiological, cognitive, behavioral, and psychosocial risks associated with varying lengths of sleep deprivation for both acute and chronic partial sleep deprivation in children, adolescents, and adults; 
- elucidate the role of evening or bedtime alcohol use in sleep deprivation, and investigate the contribution of sleep deprivation to risk-taking behaviors such as drug and alcohol consumption; 
- identify effective recovery patterns following chronic partial sleep loss and whether rates of recovery vary by age or for physiological, behavioral, and cognitive processes; 
- determine the restorative function of sleep in maintenance of health; 
- determine the relationship between menopause (natural or medically induced) and sleep disturbances; 
- develop interventions to improve the quality of sleep and to prevent sleep deprivation from occurring in healthy and chronically ill individuals across the lifespan including neonates, children, adolescents, adults, and older persons; 
Announcement

Hearst Foundation, William Randolph
Deadlines: Continuous.
Proposals may be submitted at any time. There are no formal application forms. Applicants are asked to submit a one page executive summary accompanied by a full proposal. Only one proposal from an organization will be reviewed within a calendar year. Proposals from institutions with more than one department (e.g. universities, medical centers, etc.) should be coordinated through the appropriate central office. Interests in the health field relate to improved and increased health care, while facilitating wellness, prevention, and rehabilitation. The foundation works largely through leading regional hospitals and medical centers, supporting programs to increase access for underserved urban and rural populations. Areas of interest include perinatology, pediatrics, cancer, stroke, aging, women's health issues, and research. Information
Contact: The William Randolph Hearst Foundations, 888 Seventh Avenue, 45th Floor, New York, NY 10106 Tel: (212) 586-5404

Pathogenesis and Treatment of Lymphedema
PA-01-035 (R01)
National Heart, Lung, and Blood Institute
National Institute of Child Health and Human Development
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Cancer Institute
Deadlines:   October 01, 2002, February 01, 2003, June 01, 2003
(Expires on December 31, 2003, unless reissued.)
Qualified researchers are invited to submit applications for research project grants to investigate the pathogenesis and new treatments for primary and secondary lymphedema. (Primary lymphedema is inherited in an autosomal dominant fashion, with variable expressivity and penetrance, and with women affected almost three-fold more often than men.) The purpose of this program announcement is to stimulate research on the biology of the lymphatic system, and to characterize at the molecular, cellular, tissue, organ, and intact organism levels, the pathophysiologic mechanisms that cause the disease, and to discover new therapeutic interventions. The scope of this research includes developmental biology and genetics of the lymphatic system to identify and characterize genes important for its organization and regulation. Such knowledge will help to improve early diagnosis of affected individuals, the choice and timing of treatment, and genetic counseling. Research is also needed on the pathophysiology of the disorders of skin and subcutaneous tissue secondary to chronic lymphedema, and lymphedema which results from cancers and cancer treatment, with an ultimate goal to develop more targeted and effective therapies.  Announcement

Aging

Age-Related Changes in Reading and Oral Language Comprehension
PA NUMBER: PA-01-002 (R01, P01)
National Institute on Aging
National Institute of Child Health and Human Development
Deadlines:  October 01, 2002, February 01, 2003,  June 01, 2003
Expires on February 1, 2004 unless reissued.
NIH seeks research grant applications aimed at the study of selected aspects of speech and reading comprehension as they change with age. General areas of interest include the following: 1) the factors and individual differences related to comprehending written and spoken language as well as the demography and epidemiology of age-related changes; 2) the human factors, biological factors, developmental factors, environmental factors, and the social conditions that interfere with or enhance comprehension, and research applications aimed at applying research findings; 3) the development of reading comprehension strategies, compensatory strategies, and the most effective approaches to the development and maintenance of literacy in adulthood; and 4) research applications aimed at specific domains including comprehending specific types of information (e.g., medical, legal, insurance) and maintaining professional competence. Announcement

Alzheimer's Disease Research Grants
American Health Assistance Foundation (AHAF)
Deadline: October 16, 2002
Upper Amount: $200,000
The American Health Assistance Foundation (AHAF) awards grants for basic research on the causes of or treatments for age-related and degenerative diseases. Grants in Alzheimer's disease research are awarded on the basis of the scientific merit of the proposed research and the relevance of the research to improving the understanding of Alzheimer's disease. Announcement


Mechanisms of HIV Dementia and Other CNS Diseases - NIH
NINDS, NIMH, NIDA, NIA
PAS-00-065 (R01)
Deadlines: October 01, 2002, February 01, 2003
Invites investigator-initiated research grant proposals to study potential common immunological and inflammatory mechanisms involved in the etiology of HIV-1 associated dementia (HAD) and neurodegenerative or autoimmune diseases of the nervous system such as Alzheimer's disease (AD), Parkinson's disease, and multiple sclerosis (MS). One intent of this program announcement (PA) is to encourage basic and clinical scientists who have been working in the previously disparate areas of infectious, autoimmune, and neurodegenerative disease to develop multidisciplinary collaborations to search for common factors in the causation of these and other related diseases. Announcement

NIA Pilot Research Grant Program
PAR-02-049 (R03)
National Institute on Aging (NIA)
Deadlines:  July 15, 2002, November 15, 2002
Amounts: 25,000 to 50,000
The National Institute on Aging (NIA) is seeking small grant (R03) applications in specific areas to stimulate and facilitate the entry of promising new investigators into aging research, and encourage established investigators to enter new targeted, high-priority areas in this research field. This small grant (R03) program provides support for pilot research that is likely to lead to a subsequent individual research project grant (R01) that is focused on aging or a significant advancement of aging research.
Improve Health and Quality of Life of Older People: 
1. HIV/AIDS and Aging
2. Cardiovascular and Cerebrovascular aging
3. Alzheimer's Disease Drug Discovery
4. Transmissible Spongiform Encephalopathies (TSEs)
5. Vaccine Development
6. Health-related Consequences of Female Reproductive Aging
7. Cancer in the elderly
8. Basic Research in Behavioral Medicine
9. Impact of Research on Health or Public Policy
Understand Healthy Aging Processes:
10. Stems Cells, Tissue Repair, and Cell Replacement in Aging
11. Sensory and Motor Processing
12. Cognition in Context
13. Membranes, Extracellular Matrix and Cytoskeleton
14. Functional Senescence: Genetic, physiological, cellular and biochemical mechanisms that underlie age-related changes leading to dysfunction in tissues, systems, or organs
15. Psychoneuroimmunology
16. Caloric Restriction and Aging
17. Basic Underlying Mechanisms of Musculoskeletal Aging (muscle, bone, cartilage, neuromuscular junction, peripheral nerve, and motorneuron)
18. Exceptional Human Longevity
19. Genetics, Behavior and Aging
20. Racial/Ethnic Differences and Health Disparities
Enhance Resources to Support High Quality Research: 
21. Refinements in Doubly-Labeled Water Methods for Human Studies of Effects of Altered Caloric Intake and Physical Activity
22. Animal Models of Aging
23. Tools for Research on the Genetics and Proteomics of Aging
24. Improved Measures and Methodologies
Announcement

Alcohol & Drugs

National Institute on Drug Abuse
Program Announcements Encouraging Research on Women's Health and Gender Differences
To see all the NIDA's PA's focused on gender differences click on: 
Announcements

Cutting-Edge Basic Research Awards (CEBRA)
PAR-01-047  (R21)
Deadline: October 01, 2002, February 1, 2003,  June 01, 2003
               (Expires on October 1, 2004, unless reissued)
The National Institute on Drug Abuse (NIDA) invites applications for Cutting-Edge Basic Research Awards (CEBRA) to foster highly innovative or conceptually creative research that advances our understanding of drug abuse and addiction and how to prevent and treat them
Examples of relevant research include, but are not limited to, the following:
1. Applying novel or emerging technologies--such as biosensors, nanotechnology, or proteomics--to address questions about the neurobiology of drug abuse or addiction or synaptic remodeling
2. Using molecular biology, microscopic chemistry, and biochemistry approaches to develop new methods for regulating gene and protein function in vivo, detecting protein-protein interactions, localizing proteins in the nervous system, or directly measuring synaptic activity
3. Elucidating the role of cellular processes--such as mRNA translation regulation, trafficking systems, cytoskeletal organization, protein degradation, etc.--that have not been investigated extensively in previous studies of the cellular response to drugs of abuse
4. Discovering novel drug abuse-related signal transduction pathways or previously uncharacterized "crosstalk" interactions between known pathways
5. Applying molecular, neurochemical, and genetic approaches to explain the behavioral and biological bases of gender-specific differences in response to drugs of abuse
6. Applying high resolution imaging methods to study neuronal activity in awake and moving small animals
7. Applying multiple-channel, multi-site electrophysiological recording to understand the acquisition, maintenance, and long-term neural encoding of drug-seeking and drug-taking behaviors, including comparisons with the acquisition and performance of "natural" behaviors
8. Using novel methods for high throughput screening for new drug templates or receptor-specific ligands, and developing new and faster methods to design super-agonists and antagonists for various receptor types and subtypes
9. Discerning functional interactions between non-opiate peptides and chemical neurotransmitters using methods other than anatomical or colocalization studies
10. Developing multidimensional behavioral assays capable of detecting drug-seeking or drug-taking behaviors that are guided by a range of underlying psychological processes or states
11. Using laboratory-based studies to explore vulnerability to drug dependence on the basis of sensitivity to aversive consequences or initial subjective response to drug effects
12. Developing new methods for training self-control based on contemporary cognitive science and cognitive neuroscience.
Announcement

Drug Abuse Dissertation Research: Epidemiology, Prevention, Treatment, Services, and Women and Gender Differences
PA-02-055 (R03)
Deadline: October 01, 2002, February 01, 2003,  June 01, 2003
(Expires February 1, 2005, unless reissued.)
National Institute on Drug Abuse (NIDA)
Upper Amount: $100,000
The applicant for a dissertation research grant must be enrolled in an accredited doctoral degree program in the behavioral, biomedical, or social sciences.
Historically, in drug abuse research, as in other fields of public health research, the research subjects have been almost exclusively male. Accumulating drug abuse research, however, suggests that the antecedents, consequences, and mechanisms of drug abuse and addiction are not identical in males and females and that gender may be an important variable in maximizing treatment and prevention outcomes. Thus, through this dissertation award program, NIDA seeks to foster research on females and gender differences in all areas of drug abuse research. From basic cellular and genetics research to epidemology, prevention, treatment, and services research, investigators are encouraged to explore the possible importance of gender differences in their chosen area of study or to explore drug abuse issues specific to women.
Announcement

Drug Abuse Prevention Intervention Research
PA-00-002
National Institute on Drug Abuse
Deadlines: October 01, 2002
Mechanisms of support available: research project grants (R01), small grants (R03), exploratory/ developmental grants (R21), program projects (P01), and research centers (P30, P50, and P60).
Prevention science takes a multi-disciplinary systems perspective in examining interactions, transactions, and mechanisms within and across levels of the human environment that deter the development of substance abuse patterns and addiction. To accomplish this, NIDA funds investigator-initiated research focusing on developmentally appropriate universal, selective, and indicated drug abuse prevention strategies for individuals, groups, and specific populations. NIDA recognizes there are multiple pathways to and patterns of drug abuse that may vary by geographic location, ethnicity, cultural group, lifestyle choices, gender, and individual differences. Prevention research should focus attention on (1) recognizing variations in community, ethnic, cultural, lifestyle, gender, and individual issues, concerns, and risk factors; (2) developing strategies that address these sub-population differences; and (3) understanding the processes, mechanism, and reasons why some prevention components may be universally effective whereas others must be adapted for sub-groups. Announcement

Role of Limbic System and Brain Ontogeny in Drug Abuse
PA-02-015  (R01, R21)
National Institute on Drug Abuse (NIDA)
Deadline: October 01, 2002, February 01, 2003,  June 01, 2003
                (expires on October 31, 2004, unless reissued)
Specific cortical and subcortical forebrain structures, often referred to as the limbic system, play a significant role in mediating emotional and motivated behavior as well as memory storage. The proper development of forebrain structures and the formation of neural circuitry in the forebrain are essential for the normal development of pathways that mediate the hedonic properties of food, sex, and drugs of abuse. Elucidation of the processes underlying the development of the limbic system may provide critical insights into the adaptive processes associated with addiction and provide insights into mechanisms that might underlie increased vulnerability to addiction. This initiative is designed to support basic research into the fundamental mechanisms of development of the midbrain and basal forebrain structures that mediate the euphoric properties of drugs as well as understanding how drugs of abuse affect the cellular and molecular mechanism underlying nervous system development.

Examples of research that may be considered responsive to this PA include, but are not limited to, those listed below. In all research areas, investigators are encouraged to analyze developmental mechanisms that contribute to sexual dimorphisms.
1. Neural induction and pattern formation
2. Stem cells and progenitors
3. Cell fate and specification
4. Neural and glial differentiation
5. Cell migration
6. Process outgrowth, navigation, and target selection
7. Synapse formation and plasticity during development
8. Programmed cell death
Announcement

Secondary Analysis of Existing Alcohol Epidemiology Data Sets
PA-01-140 (R01, R21)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Deadline: October 01, 2002, February 01, 2003, June 01, 2003
                 (expires on October 5, 2004, unless reissued)
Research grants for the Secondary Analysis of Existing Alcohol Epidemiology Data Sets are intended to provide support for studies that more fully utilize currently available data sets to increase our understanding of the incidence, prevalence, and etiology of alcohol-related problems and disorders in the population, as well as the risk and protective factors associated with them. Data used in secondary analyses may be obtained from current or past investigator-initiated research activities or from other public or private sources. Research that employs analytic techniques which demonstrate or promote methodological advances in alcohol-related epidemiologic research is also of interest.
Research objectives of this program announcement (PA) include, but are not limited to
- studying patterns of alcohol consumption and the distribution of alcohol-related problems in the population as a whole and in specific sub-populations;
- studying risk and protective factors for alcohol-related problems in the population as a whole and in specific sub-populations;
- elucidating disparities among racial and ethnic groups with respect to alcohol consumption and alcohol-related problems; and
- understanding the natural history, course, and short- and long-term outcomes of alcohol consumption.
Announcement

Alternative & Complementary Medicine

Complementary and Alternative Medicine (CAM) Education Project Grant - NIH NCCAM, NCI
PAR-00-027 (R25)
Deadline:  October 1, 2002
Up to $1,500,000
Many of the Nation's conventional medical, dental, and nursing schools have begun to incorporate information about CAM practices and training in alternative modes of healing into their curriculum. The NCCAM intends to play a proactive role in accelerating this process by supporting the development, refinement and expansion of innovative new educational approaches to incorporate CAM information into the medical, dental, nursing, and allied health professional school curriculum, into residency training programs, and into Continuing Education (CE) courses. Announcement

Autoimmune / Immune

Autonomic Nervous System Dysfunction in CFS
Chronic Fatigue and Immune Dysfunction Syndrome (CFIDS) Association of America, Inc.
Research Grants Program
Deadline: Letters of intent are due by October 15, 2002. (Anticipated)
               Invited full applications are due November 26, 2002
Amount:  from $30,000 to $80,000
The CFIDS Association of America is pleased to announce the availibility of Chronic Fatigue Syndrome (CFS) research grants for pilot projects on the role of autonomic nervous system dysfunction in CFS in the following targeted areas
- characterization of the integrity of ANS function in CFS, using a variety of complementary techniques;
- elucidation of the relationships among the HPA axis, ANS and immune system and how these relationships contribute to the cardiovascular regulatory complications and the immune function alterations experienced by some people with CFS;
- potential contribution of inflammatory cytokines modulated by the ANS to the symptom complex of CFS;
- impact of reported perfusion alterations on the brain stem in CFS and whether these changes are primary or secondary to peripheral neuroendocrine and autonomic alterations in CFS; and
- exploratory testing of hypothesis-driver therapeutic interventions in well-characterized subpopulations of people with CFS with autonomic nervous system dysfunction.
Announcement

Identifying Functional Links Between the Immune System and Brain Function Including Behavior
PA-02-045 (R01)
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke 
National Institute on Drug Abuse
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Deadline: October 01, 2002, February 01, 2003,  June 01, 2003
(Expires 2/05)
The potent effects of cytokine molecules in the brain are mediated through multiple signaling pathways. However, details regarding the extent, routes, or mechanisms whereby immune signaling molecules affect the brain in either normal conditions or during immune challenge are largely unexplored. The purpose of this PA is to identify research themes that may help to bridge the gap in understanding how immune mediators affect brain function and behaviors related to cognition and mood. This includes studies of the effects of immune molecules and cells on molecular and cellular neural processes, neuronal signaling, glial-neural interactions, neural activation, and objective behavioral endpoints of relevance to mood, cognition, and motivation. Studies examining immune molecule effects on neurodevelopment and across the lifespan as well as studies comparing effects in males and females are also encouraged. It should be noted that studies aimed at examining how the brain or stressors affect peripheral immune function are not appropriate for this solicitation. Similarly, studies of immune cell entry and fate in brain are appropriate only if they examine how these cells affect ongoing brain processes and/or behavior.
Announcement

Lupus Foundation of America Research Grant Program
Deadline: April 1st of each year
$25,000 per year for up to two years
Clinical, basic or psychosocial research related to the causes, treatments, prevention or cure of lupus. Junior investigators - assistant professor and below rank if in academic medicine -are eligible to apply. First year Fellows are not eligible. Announcement

Mechanisms of HIV Dementia and Other CNS Diseases - NIH
NINDS, NIMH, NIDA, NIA
PAS-00-065 (R01)
Deadlines:  October 01, 2002, February 01, 2003
Invites investigator-initiated research grant proposals to study potential common immunological and inflammatory mechanisms involved in the etiology of HIV-1 associated dementia (HAD) and neurodegenerative or autoimmune diseases of the nervous system such as Alzheimer's disease (AD), Parkinson's disease, and multiple sclerosis (MS). One intent of this program announcement (PA) is to encourage basic and clinical scientists who have been working in the previously disparate areas of infectious, autoimmune, and neurodegenerative disease to develop multidisciplinary collaborations to search for common factors in the causation of these and other related diseases. Announcement

Multiple Sclerosis Society
Deadlines: 
Research Grants - February 1 and August 1
Pilot Research Projects - none
Junior Faculty Awards, Senior Faculty Awards, Physician Fellowships, Postdoctoral 
Fellowships, Advanced Postdoctoral Fellowships - February 1

The National Multiple Sclerosis Society will consider any bona fide request for research or training support relevant to the Society's mission. Research and training with direct applicability to individuals with multiple sclerosis is encouraged wherever practical and possible. For investigator-initiated support requests, no topic restrictions are imposed, other than the required demonstration of relevance to multiple sclerosis. However, recent advances point to topics of particular current importance and interest for multiple sclerosis research , including:

• immunologic basis of MS, including pathophysiology,monitoring of disease activity and treatment; 
• myelin biology and neurobiology, with a focus on basic and applied knowledge that will lead to control breakdown, restoration of myelin and neurophysiologic and functional recovery; 
• susceptibility to MS, including genetic, gender-related, and other factors; 
• infectious disease processes that may trigger disease activity; 
• measures of disease activity, including imaging technology and the identification and use of surrogate markers; 
• clinical trials and implementation of appropriate therapeutic interventions aimed at modifying the underlying disease course and disease symptoms; 
• health care delivery/policy, cognitive, psychosocial and rehabilitation research aimed at improving quality of life for those affected by multiple sclerosis.
  Announcement (Search for Research Funding)

Research on Sex Differences in Multiple Sclerosis
Obtain application forms and information by contacting the Research Programs
Department, National Multiple Sclerosis Society, 733 Third Avenue, New York,
NY 10017, or call (212) 476-0413.

Supplemental Funds to NMSS Grants - The principle investigator will propose to expand their currently funded NMSS project to gather data permitting analysis of sex-based differences that would not otherwise be obtained.

The Basis for Sexual Dimorphism in Multiple Sclerosis - The National Multiple Sclerosis Society invites investigators to submit research proposals focused in the following research areas: sexual dimorphism in the immune response; mechanisms underlying the hormonal effects on the immune response & autoimmunity; natural and induced hormonal fluctuations and the immunology of pregnancy; genetic factors that control autoimmune disease as well as clinical 
research on sex-related differences in disease course.

Neuroendocrine Dysfunction in CFS
Chronic Fatigue and Immune Dysfunction Syndrome (CFIDS) Association of America, Inc.
Research Grants Program
Letters of intent are due by October 15, 2002.(anticipated)
Invited full applications are due November 26, 2001
Amount:  from $30,000 to $80,000
The CFIDS Association of America is pleased to announce the availbility of CFS research grants for pilot projects on the role of neuroendocrine dysfunction in Chronic Fatigue Syndrome (CFS) in the following targeted areas
- prospective studies of hypothesized CFS risk or etiological factors, i.e., infections, trauma, etc.;
- development of human experimental models that temporarily recreate the symptoms of CFS (i.e., administration of cytokines such as IL-6; post-partum sleep, mood, cognitive, and hormonal changes; etc.);
- significance of menarche, menstrual cycle, pregnancy, menopause, and other female gender-specific issues across the life cycle;
- evaluation of the impact of pregnancy hormones on symptoms of CFS, including their potential role in the treatment of CFS;
- studies to clarify conflicting reports on abnormalities in the HPG axis and circulating androgens;
- polysomnographic studies of CFS, focusing on the relationship between sleep disturbances, daytime fatigue, varied levels of physical activity, and alterations in pain threshold; and
- the role of neuroendocrine changes on CFS in adolescents and children.
Announcement

Pathophysiology and Treatment of Chronic Fatigue Syndrome
PA-02-034 (RO1)
Office of Research on Women's Health 
Office of Dietary Supplements 
Office of Behavioral and Social Science Research 
National Center for Complementary and Alternative Medicine 
National Institute on Alcohol Abuse and Alcoholism 
National Institute of Allergy and Infectious Disease 
National Institute of Arthritis and Muscular Skeletal and Skin Disease 
National Institute of Child Health and Human Development 
National Heart, Lung and Blood Institute 
National Institute of Environmental Health Sciences 
National Institute of Nursing Research
Deadline:  October 01, 2002, February 01, 2003,  June 01, 2003
               (Expires on January 10, 2005, unless reissued.)
Well designed studies are needed to provide a better understanding of both CFS pathogenesis and pathophysiology with the goal of developing improved diagnostic and intervention strategies. Studies should test biologically rational hypotheses. In clinical studies, selection criteria and procedures for CFS case and comparison groups should be carefully delineated and appropriate for the hypothesis under study. The heterogeneity of CFS population should be considered; thus both sub group analysis and collaborative, multidisciplinary research within or across scientific disciplines and institutions are encouraged. Human studies should include appropriate sample sizes to allow for analysis of sex, age /developmental period and racial/ethnic group differences.

Examples of multisystemic factors that may explain or have an impact on CFS pathogenesis and pathophysiology, and that are of interest to the NIH have been arbitrarily sorted into crosscutting categories that include all interested disciplines. Areas in which such scientific opportunities exist include, but are not limited to, epidemiology; methodology; basic scientific understanding of symptoms and disrupted physiologic control; and treatment and quality of life.
Announcement

Scleroderma Foundation 
Research Funding Program
Deadline: September 15, 2002 (anticipated)
The Scleroderma Foundation Research Funding Program is currently accepting proposals for research grants related to scleroderma. Each application should have the quality of an NIH proposal. Projects of investigators new to the field of scleroderma are preferred, although studies in new directions by established researchers will be considered.
Announcement

Cancer

Aging Women and Breast Cancer 
PA-00-001 (R01, R29)
NCI 
Deadlines:   October 01, 2002
Breast cancer affecting elderly women is a major health problem. The purpose of this broad-based program announcement is to expand the knowledge base on breast cancer in older women through studies in the fields of biology, clinical medicine, epidemiology, and the behavioral and social sciences.
Announcement

Economic Studies in Cancer Prevention, Screening and Care
NCI, AHCQ, NIDCR
PA-99-014 (R01)
Application due: October 01, 2002, February 01, 2003
The goal of this program announcement is to generate new economic knowledge that will promote the optimal design of cancer prevention and control trial studies and interventions and will facilitate the formulation of effective health care policy related to cancer prevention and control. This initiative requests research applications on new methods development, the synthesis and extension of existing methods, and innovative data gathering strategies. Three broad topics are included in this announcement: 1. The cost of cancer treatment and care in various organizational settings. 2. Collection of economic data in the context of clinical trials and the use of economic data and analysis in the design of trials. 3. Cost-effectiveness of cancer prevention and screening trials and cancer prevention and control interventions.
Announcement

Exploratory Studies in Cancer Detection, Prognosis, and Prediction 
PA-01-010 (R21)
National Cancer Institute (NCI)
Deadlines: October 01, 2002  
                   (expires on October 2, 2002)
The Division of Cancer Treatment and Diagnosis and the Division of Cancer Prevention of the National Cancer Institute (NCI) invite research grant applications from interested investigators to explore innovative strategies for the early detection of cancer, assessment of cancer prognosis, or prediction of response to cancer treatment. Advances in the understanding of basic cancer biology and the development of powerful molecular technologies are leading to the identification of many new abnormalities in precancerous and cancer cells. This initiative promotes the initial evaluation of molecular or cellular characteristics in human specimens or the development of assays that may result in important advances in the detection, diagnosis, and treatment of cancers. Announcement

Friends...You Can Count On
Small Grants in Cancer Detection/Screening
Deadline: October 15, 2002 (anticipated)
Friends...You Can Count On is requesting applications for pilot projects that focus on new methods to improve detection of early breast cancer, and is especially interested in the development of new techniques in the areas of biological or immunologic methods to detect early stage breast cancer. Awards of up to $40,000 (total costs) are being offered, which may be used over a one- to three-year period of time at the discretion of the investigator. Grants are for direct costs only.
Announcement

Genomic Imprinting & Environmental Disease Susceptibility - NIH
NIEHS
PA-00-034 (R21)
Deadlines:   October 01, 2002
This PA is to encourage applications from individuals who are interested in testing novel or conceptually creative ideas to understand the potential role environmental agents play in causing epigenetic changes in the DNA that can alter imprint gene expression, thereby resulting in a multitude of genetic diseases including cancer and neuro-behavioral disorders. Announcement


Research Scholar Grants for Beginning Investigators
American Cancer Society
Deadlines: April 1 and October 15
Offer funding up to $250,000 a year for a period of four years with an option for renewal for an additional four years. These grants support basic, preclinical, clinical, cancer control, health services, health policy, or epidemiologic research projects initiated by investigators in the first eight years of their independent research careers. 
Announcement

Research Scholar Grants for Health Services and Health Policy and Outcomes Research
American Cancer Society
Deadlines: April 1 and October 15
Offer funding up to $250,000 a year for a period of four years, renewable for an additional four years. These grants support research projects centered on health services and health policy outcomes research that are initiated by investigators at any stage of their careers. Announcement

Research Scholar Grants in Psychosocial and Behavioral Research
American Cancer Society
Deadlines: April 1 and October 15
Provide up to $500,000 per year for five years with optional renewal for an additional five years. These grants support research projects centered on the psychosocial and behavioral aspects of cancer and are for independent investigators at any stage of their careers. Announcement

Susan G. Komen Breast Cancer Foundation
Grants and Funding Opportunities 
   
Basic, Clinical and Translational Research
The program offers 2-year grants of up to $250,000 over 2 years (combined direct and indirect costs)
Focus areas:
Detection and Diagnosis
Prognosis
Risk, Prevention and Epidemiology
Local Treatment
Psychosocial Treatment
Systemic Treatment
Tumor Cell Biology
Complementary and Alternative Health

Imaging Technology
A program designed to research and develop methods for early detection and diagnosis of breast cancer. Grants are awarded up to $250,000 over 2 years (combined direct and indirect costs).

Population Specific Research
Innovative projects focusing on the epidemiology of breast cancer within specific populations at risk for the disease. The focus of the program is to identify unique needs, trends, barriers and risk factors to breast health care among populations such as African American, Asian/Pacific Islanders, Hispanic/Latina, Native American, Lesbian and Low Literacy. Applicants are also encouraged to demonstrate collaboration with a community-based organization. Grants are awarded for 2 years, up to $250,000 (combined direct and indirect costs).

Postdoctoral Fellowships
Available in basic, clinical, translational research, public health or epidemiology. Grants are awarded for three years. $35,000 per year. Area of study is limited to breast cancer.

Dissertation Research
A program to fund doctoral candidates in the health and social sciences to conduct dissertation research on breast health and breast cancer. Funding of $20,000 to $30,000 over two years is available. Focus areas include health sciences and basic research. 
Announcement

Targeted Clinical Research Training Grants for Junior Faculty: Research Directed at Poor and Underserved Populations
American Cancer Society (ACS)
Deadline: October 15, 2002
The Targeted Clinical Research Training Grant for Junior Faculty is open to applicants in the first four years of their faculty appointment. The society has identified a critical need for research on prevalence, early detection, prevention, and treatment of cancer in poor and underserved populations. Despite the progress in the fight against cancer that has seen a steady decline in cancer incidence and mortality rates since 1992, some Americans continue to bear a disproportionate share of the cancer burden. Poor Americans, irrespective of race, have a 10 to 15 percent decreased rate of survival from cancer compared to the general population. Smoking has become increasingly concentrated among socioeconomically disadvantaged Americans. Smoking among adults with less than a high school education decreased by only 14 percent compared to 58 percent among adults with at least a college degree. The ACS is very concerned about this disparity in cancer incidence and mortality and wants to support research to address this problem. Proposals submitted in response to this RFA must focus on poor or underserved populations, but may address a variety of behavioral, epidemiological, policy, health delivery, clinical and basic science issues. Interdisciplinary collaborations are encouraged and the novelty and uniqueness of the proposed projects will be an important aspect in the evaluation process. . Examples are studies dealing with early detection strategies and outcome, how to achieve broader access and willingness to utilize mammography, PSA determination, colonoscopy, and other early detection procedures. Cancer prevention strategies are another example. These include, but are not limited to, the identification of risk factors and how they might be modified by dietary means, physical activity, protection from sun, and of course abstention from smoking. Also included within this RFA are proposals dealing with national and local policies that affect the availability of health care and health care delivery to specific population groups. Studies to identify molecular determinants that may put poor and underserved populations at higher risk of cancer incidence and progression, with the specific purpose of developing strategies to overcome or eliminate these risks, will also be considered. Announcement

Cardiovascular

Cardiac Care Award
Alpha Phi Foundation
Deadline: April of each year
Upper Amount: $20,000
One of the Alpha Phi Foundation's charitable priorities is the study of heart disease and its treatment. As a women's organization, the foundation places special emphasis on women's cardiac care. Each spring the foundation accepts nominations for the Alpha Phi Foundation Cardiac Care Award. Examples of those who might be nominated include: research programs; community education efforts; hospitals; schools; or universities. Collegiate chapters, alumnae chapters, or individual members of Alpha Phi can make nominations for foundation monetary grants for organizations within their own communities
Announcement  

Clinical Research

Mentored Patient-Oriented Research Career Development Award - NIH
PA-00-004 (K23)
Deadlines:  October 01, 2002
Purpose is to support the career development of investigators who have made a commitment to focus their research endeavors on patient-oriented research. This mechanism provides support for three to five years of supervised study and research for clinically trained professionals who have the potential to develop into productive, clinical investigators focussing on patient-oriented research. Announcement

Midcareer Investigator Award in Patient-Oriented Research - NIH
PA-00-005 (K24)
Deadlines:    October 01, 2002
Up to $25,000 per year to provide support for clinicians to allow them protected time to devote to patient-oriented research and to act as mentors for beginning clinical investigators. The target candidates are outstanding clinical scientists who are actively engaged in patient-oriented research. Candidates are generally within 15 years of their specialty training. Candidates must be able to demonstrate the need for a period of intensive research focus as a means of enhancing their clinical research careers and must be committed to mentoring the next generation of patient-oriented researchers. Announcement

Disabilities

Environmental

Gender-Specific / Women's Health

Charles E. Gibbs, M.D. Leadership Award
Jacobs Institute of Women's Health
Deadline: Continuous
Amount: $1,000
The Charles E. Gibbs Leadership Award is offered by Jacobs Institute for the best manuscript published in Women's Health Issues in a given volume.
Announcement

Ortho Pharmaceutical Scholar in Women's Health Care
Jacobs Institute of Women's Health
Deadline: October 15, 2002 (anticipated)
Amount: $30,000
To be eligible, candidates must have a health care related degree and be actively involved in women's health care or research. (Ph.D./M.D./Other Professional)
The Jacobs Institute of Women's Health has established a research grant to support efforts to find new ways to improve health care services for women. The grant is given to the selected applicant to conduct a research study resulting in a publication-quality manuscript on a topic related to women's health. The research may focus on a number of areas, including the following:
- the changing health care environment;
- the unmet need for primary and preventive health services;
- the historic lack of research on women's health care issues; or
- any of the social, cultural, legal, economic, or behavioral factors that currently influence women's health care opportunities.
The award is directed toward the objectives of the institute. It is not intended to support basic laboratory research, nor to evaluate local projects that cannot be generalized.
Announcement

HIV/AIDS

HIV Pathogenesis in Women's Interagency HIV Study (WIHS) - NIH
PA-01-084 (R01)
Deadlines: September 01, 2002, January 01, 2003, May 01, 2003
                   (expires January 3, 2004, unless reissued)
Applications for highly focused, basic research integrated with the Women's Interagency HIV Study (WIHS) scope and structure. Applications are expected to utilize the WIHS study population, a large cohort of HIV-infected women in the United States, to formulate specific hypotheses concerning HIV/AIDS pathogenesis in women. The WIHS cohort is followed in five large metropolitan areas (New York; Washington, District of Columbia; Chicago; Los Angeles; and San Francisco). Applications are invited to conduct studies focused on basic mechanisms of HIV infection and progression in women.

Scientific questions addressed by studies submitted under this Program Announcement may utilize biological specimens already collected and banked or specimens to be prospectively collected. Use of WIHS specimens will be restricted to the use 0stated in the grant. To address any peer review's concerns regarding specimen access, applicants are advised to provide documentation of the establishment of a collaboration with the WIHS investigators. Inquiries on this matter should be directed to the Program staff of the participating NIH Institutes.
Announcement

Mechanisms of HIV Dementia and Other CNS Diseases - NIH
NINDS, NIMH, NIDA, NIA
PAS-00-065 (R01)
Deadlines: October 01, 2002, February 01, 2003
Invites investigator-initiated research grant proposals to study potential common immunological and inflammatory mechanisms involved in the etiology of HIV-1 associated dementia (HAD) and neurodegenerative or autoimmune diseases of the nervous system such as Alzheimer's disease (AD), Parkinson's disease, and multiple sclerosis (MS). One intent of this program announcement (PA) is to encourage basic and clinical scientists who have been working in the previously disparate areas of infectious, autoimmune, and neurodegenerative disease to develop multidisciplinary collaborations to search for common factors in the causation of these and other related diseases. Announcement  

Research on Social Networks and HIV Risk Prevention
PAS-01-068   (R01)
National Institute of Child Health and Human Development 
National Institute on Alcohol Abuse and Alcoholism
National Institute of Mental Health
Deadline: September 01, 2002, January 02, 2003, May 01, 2003 
(Expires three years from the release date of March 15, 2001, unless reissued.)
This Program Announcement calls for basic, applied, and methodological research that can advance knowledge about the influence of social networks on HIV risk and the application of that knowledge to HIV prevention and treatment efforts. It invites applications for research that will extend existing knowledge of how the structure, function, and content of social and sexual networks influence HIV risk and transmission, and advance the development of prevention and treatment approaches based in social network theory and methods. Through this announcement, the National Institute of Child Health and Human Development (NICHD) seeks to advance scientific knowledge and strategies directed at the sexual transmission of HIV in vulnerable populations, especially including adolescents, young adults, and minority populations, as does the National Institute of Mental Health (NIMH). The National Institute on Alcohol Abuse and Alcoholism (NIAAA) seeks to expand prior work on the role of social environmental influences on alcohol consumption and sexual risk behaviors by systematically examining the relationships among social environmental factors, alcohol use, sexual risk behaviors, and sexually transmitted infections (STI) for groups at high risk of acquiring and transmitting STIs. Announcement

 Menopause

Biology of the Menopausal Process and Associated Health Conditions
During and After Menopause 
PA-01-067   (R01)
National Institute on Aging National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Child Health and Human Development National Institute of Diabetes and Digestive and Kidney Diseases
Deadline:  October 01, 2002, February 01, 2003, June 01, 2003
(Expires on July 1, 2004, unless reissued)
This program announcement invites research applications focused on the underlying biologic mechanisms of molecular regulatory factors (a) acting within and external to the H-P-O axis that are responsible for female reproductive aging processes, and (b) secreted from the H-P-O axis of women that serve to maintain extra-ovarian tissue (e.g., cardiovascular, bone, urinary, brain) function and diminish their protective effects during the peri- or postmenopausal periods. The goal is to increase our understanding of the molecular basis of the normal menopausal process occurring in women generally between the ages of 45 and 55. Premature ovarian failure, due either to iatrogenic or pathologic processes, is not within the scope of this program announcement. However, this restriction is not intended to exclude research with animal or other models in which ovarian follicular exhaustion is manipulated experimentally or genetically to explore relationships of reproductive aging with follicular number.  
Announcement

Mental Health

Basic and Translational Research in Emotion 
National Institute of Mental Health
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Cancer Institute
National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Neurological Disorders and Stroke
PA-00-105 (R01)
Deadlines:  October 01, 2002, February 01, 2003, June 01, 2003

Up to $250,000 direct costs per year The study of emotion encompasses a wide range of psychological, social, developmental, and biological phenomena, including characteristic expressive signals, alterations in physiology, and subjective feeling states. Central and autonomic nervous system (CNS, ANS) activity and the role of cognitive processing in emotion also are important objects of study, as is the contribution of emotional and motivational systems to cognitive faculties such as perception, attention, memory, and motor control. In addition, the study of emotion includes overt behavioral responses such as aggression or withdrawal, interpersonal relationships and communication, and environmental circumstances and experiences that elicit and shape emotion. Emotion research can also include the study of licit and illicit psychoactive substances that alter mood states, and conversely, the study of how emotional and mood states can predispose to, or modulate the effects of, pain or alcohol and psychoactive substances. This PA also encourages research on emotional reactions in the context of the diagnosis and treatment of cancer, and the study of emotion as it relates to this disease or increased risk of this disease, including outcomes such as social relationships, health care provider relationships, adherence and others. Although most emotion research involves human populations, animal models of emotion are also valuable for the investigation of particular aspects of emotion and its eliciting contexts. 
Announcement

Basic and Translational Research in Emotion: Small Grants
National Institute of Mental Health
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Cancer Institute
National Institute of Child Health and Human Development
National Institute on Drug Abuse
PA-00-106 (R03)
Deadlines: October 01, 2002, February 01, 2003, June 01, 2003
Up to $50,000 per year
The study of emotion encompasses a wide range of psychological, social, developmental, and biological phenomena, including characteristic expressive signals, alterations in physiology, and subjective feeling states. Central and autonomic nervous system (CNS, ANS) activity and the role of cognitive processing in emotion also are important objects of study, as is the contribution of emotional and motivational systems to cognitive faculties such as perception, attention, memory, and motor control. In addition, the study of emotion includes overt behavioral responses such as aggression or withdrawal, interpersonal relationships and communication, and environmental circumstances and experiences that elicit and shape emotion. Emotion research can also include the study of licit and illicit psychoactive substances that alter mood states, and conversely, the study of how emotional and mood states can predispose to, or modulate the effects of, pain or alcohol and psychoactive substances. This PA also encourages research on emotional reactions in the context of the diagnosis and treatment of cancer, and the study of emotion as it relates to this disease or increased risk of this disease, including outcomes such as social relationships, health care provider relationships, adherence and others. Although most emotion research involves human populations, animal models of emotion are also valuable for the investigation of particular aspects of emotion and its eliciting contexts.
Announcement

Mental Health Research in Eating Disorders
PA-96-064 (R01, R03, R25)
National Institute of Mental Health (NIMH)
Deadlines:   October 01, 2002
The NIMH invites applications for studies relevant to the neuroscience, epidemiology, etiology, treatment, services research, and prevention of eating disorders (anorexia nervosa, bulimia nervosa, and binge eating disorder), and their comorbidity with other medical, dental, craniofacial, and psychiatric disorders. The purpose of this program announcement (PA) is to promote additional mental health research emphasis on the broad array of influences, including gender, on eating disorders and ingestive behaviors.

Eating disorders research applications are welcome in the following broad areas:

• neuroscience and behavioral science;
• epidemiology, including comorbidity with other medical and psychiatric disorders and genetic studies;
• behavioral medicine;
• treatment studies; and
• services research.

Women's Mental Health and Gender Differences Research
PA-00-074  
Department of Health and Human Services (DHHS)
National Institutes of Health (NIH)
National Institute of Mental Health (NIMH)
Deadlines:  October 01, 2002, February 01, 2003

The National Institute of Mental Health (NIMH) invites grant applications from investigators for research on women's mental health and gender-related differences in mental disorders. This program announcement identifies five areas for research emphasis. Because of the complexity of factors influencing women’s mental health, multidisciplinary, multi-method research is encouraged. Despite clear gender differences in prevalence of different mental disorders, there is relatively little linkage between epidemiological, etiological and intervention research. In this announcement, therefore, translational research is strongly encouraged.

Examples:
Gender differences in brain and behavior including structural and functional brain imaging of normative and clinical samples.
Gender differences in the molecular and cellular bases of behavior, e.g. neurotransmitter levels and transporters, receptor subpopulations and enzyme levels.
Gender differences in genetic factors, including differences in gene expression or gene-environment interaction in relation to mental disorders.
Gender differences in the developmental-organizing and activating influences of sex steroids on brain and behavior and interactions with thyroid- and hypothalamic-pituitary adrenal axes, the immune system and neurotransmitters.
Gender differences in the pharmacokinetics, pharmacodynamics and pharmacogenetics of psychotropic medications in relation to hormonal status and developmental phase.

Examples:
Appetite, aggression, exploration, sleep, energy, mood and their biological rhythms as they are differentially regulated and dysregulated in males and females and in relation to mental disorders.
Developmental differences in males and females in risk for, exposure to, and response to, social and physical environmental variables, including stressors and trauma.
- The impact of stress at different developmental stages on gender- differentiated physiological and behavioral responses and risk for mental disorders.
- Biological, psychosocial and psychopathological correlates and consequences of violence and abuse of women and girls Epidemiological and clinical studies of disorders.
Announcement

Musculoskeletal

New Research Strategies for Evaluation and Assessment of Bone Quality
RFA-AR-02-002 (R01, R21)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Dental and Craniofacial Research
Letter of Intent Receipt Date: February 21, 2002 
Application Receipt Date: March 21, 2002

The progressive or sudden loss of bone very commonly leads to osteoporosis, a condition characterized by increased skeletal fragility and susceptibility to fracture. Osteoporosis and its consequences are a significant cause of frailty, morbidity, and even mortality among the elderly. However, while reduced bone mass is important both in contributing to and predicting an enhanced risk of fracture, low bone mass alone is not a sufficient explanation for osteoporotic fractures. This is exemplified by the substantial overlap in bone density between normal individuals and those who sustain hip and other osteoporotic fractures. Recently, gender-related differences in fracture susceptibility have been identified that cannot be explained by simple differences in bone size. It has become apparent that the conceptual basis of skeletal integrity must be broadened to include, in addition to bone mineral content, qualitative factors that may impact on bone strength such as geometry, macro and micro-structural organization, distribution of material within bone, biochemical composition, and the burden of unrepaired microdamage.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) invites research applications that provide novel means to assess bone quality and elucidate the relationships among disease- and aging-related changes in bone quality, gender-related variations in bone quality, and increased bone fragility and fracture susceptibility. Current tools for the precise assessment of fracture risk are limited. In order to target high-risk populations for preventive or therapeutic interventions, it is necessary to have tools that are able to assess bone strength and quality.
Announcement

Receptors and Signaling in Bone in Health and Disease 
PA-00-017 (R01)
NIDDKD, NIAMSD, NIDCR, NIA, NICHHD
Deadlines:   October 01, 2002, February 01, 2003
The objective of this initiative is to elicit grant submissions that focus on systemic hormones, local growth factors, and bone-active cytokines, their receptors and mechanisms of signaling in bone. While the primary focus is on basic research, the long-term emphasis is on identifying mechanisms or processes related to hormone action with potential applicability as targets for therapeutic agents that may have efficacy in the treatment of diseases that adversely affect bone, such as osteoporosis and primary hyperparathyroidism. 
Announcement

Neurological

Rett Syndrome: Genetics, Pathophysiology, and Biomarkers
PAS-99-037  (R01, R03, R21)
NINDS
Deadline:  October 01, 2002
This program announcement (PA) focuses on neurobiological studies relevant to understanding the genetic and pathophysiological basis of Rett Syndrome and for developing reliable biological markers. Applications submitted in response to this PA may address one or more of the following topics in the context of Rett Syndrome:
- epidemiological studies to characterize the environmental or genetic basis of Rett Syndrome, including studies of the rare familial cases or contrasting familial and sporadic cases;
- neurodevelopmental and longitudinal studies to characterize the neuropathological progression and inherent variability in this disorder in order to develop specific hypotheses about the initial (primary) abnormality;
- studies of other neurological conditions and clinical abnormalities that co-occur in the families of individuals with Rett Syndrome, which may have some common biological or environmental basis;
- histological, neurochemical, brain-imaging, and structure-functional studies to define the molecular, cellular, or biochemical basis of this disorder;
- studies of tissues, cells, and DNA isolated from affected individuals, in order to develop specific hypotheses about the basic abnormalities involved in Rett Syndrome;
- studies on genetic mechanisms, candidate genes, and chromosomal regions that have been implicated in Rett Syndrome;
- relevant studies of X-inactivation, imprinting, positional effects, and gender-specific aspects of gene regulation;
- studies on potential gender-specific mechanisms (e.g., genetic, hormonal, neurodevelopmental) that may explain the apparent occurrence of Rett Syndrome solely in females;
- studies to define specific biological markers that would be useful for the diagnosis, screening, or treatment of Rett Syndrome;
- hypothesis-based therapeutic strategies for managing the devastating symptomatology of Rett Syndrome; and
- development and use of animal models that have specific relevance to Rett Syndrome based on clear neurodevelopmental, pathophysiological, genetic, or functional homology.
Announcement

Obesity

Physical Activity and Obesity Across Chronic Diseases
PA-01-017 (R01)
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Child Health and Human Development
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Nursing Research
Deadlines:   October 01, 2002
These Institutes invite applications from investigators for research studies that will address the relationship between physical activity and obesity. Three general areas of research are encouraged: (1) studies (including observational and prospective) examining physical activity and obesity relationships; (2) studies to improve methodology of assessment of physical activity and energy balance; and (3) studies to test intervention approaches that incorporate physical activity for obesity prevention or treatment related to chronic diseases.
Announcement

Oral Health

TBA

Pain

Interstitial Cystitis Association 
See below under "Urinary"

The Management of Chronic Pain
PA-01-115 (R01)
National Institute of Nursing Research (NINR)
National Institute on Aging (NIA)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Center for Complementary and Alternative Medicine (NCCAM)
National Cancer Institute (NCI)
National Institute of Child Health and Human Development (NICHD)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute on Drug Abuse (NIDA)
National Institute of Neurological Disorders and Stroke (NINDS)
Deadline:  October 01, 2002, February 01, 2003, June 01, 2003
     (Expires on July 31, 2004, unless reissued)
The National Institute of Nursing Research and co-sponsoring Institutes and Centers encourage research proposals in the management of chronic pain across the lifespan. Pain is a subjective experience influenced by gender, age, race/ethnicity and psychosocial factors. The management of pain is influenced by patient, health care provider and system factors. Research is needed to determine the most effective interventions to remove barriers to effective treatment, to determine the most effective pharmacological and non-pharmacological therapies including complementary and alternative therapies, to identify assessment tools for patients unable to verbalize their pain, and to identify effective pain management strategies for individuals with disabilities and underserved populations.
Announcement

New Approaches to the Pathogenesis and Treatment of Orofacial Pain
PA-01-108  (R01)
Department of Health and Human Services (DHHS)
National Institutes of Health (NIH)
Office of the Director (OD)
Office of Research on Women's Health (ORWH)
Deadline:  October 01, 2002, February 01, 2003, June 01, 2003
     (Expires on June 30, 2004, unless reissued.)
The Office of Research on Women's Health (ORWH) invites research grant applications for innovative basic research investigations to study the pathogenesis of orofacial pain, in particular temporomandibular disorders (TMDs). A broad range of research proposals on pathogenic mechanisms, new animal models, and interventions to halt and reverse disease processes is encouraged. The ORWH encourages collaborative projects that bring together investigators from all relevant scientific disciplines including molecular and cellular biology, immunology, endocrinology, biochemistry, pathology, and chemistry interested in studying this problem. 
Examples of specific research topics include
- animal models of specific pathophysiologic conditions that produce orofacial pain, in particular, ones that induce temporomandibular dysfunction;
- genetic predisposition as a factor in differential responses to insults that produce orofacial pain and TMDs;
- defining unique molecular or physiological differences in the components of the orofacial region that may be relevant to orofacial pain syndromes;
- development and use of biological markers and surrogate end points to objectively classify types of orofacial pain, and for use in the development of new therapeutic strategies;
- peripheral and central sensitization of nociceptors, in particular, as it relates to stimuli or lesions known to induce orofacial pain;
- state of the art analgesic approaches for alleviation of orofacial pain; and
- the design and development of controlled release delivery systems for delivery of both conventional and new drugs at targeted specific sites of the temporomandibular joint (TMJ) to alleviate pain and inflammation.
Announcement

Reproductive Health

Reproductive Genetics
PA-01-005 (R01, R03)
Deadlines:  October 01, 2002, February 01, 2003, June 01, 2003
Expires on November 1, 2003, unless re-issued
National Institute of Child Health and Human Development
The purpose of this initiative is to support new studies on the genes and genetic mechanisms influencing sex determination, human fertility, the role of differential expression of parental alleles (i.e., genomic imprinting and X-inactivation) in reproduction, and other topics in reproductive genetics. The studies targeted by this program announcement are expected to identify and characterize the relevant genes, determine their function in normal human reproduction and reproductive development, identify functional partners and the nature of their interactions, and further our understanding of the multiple adverse health consequences of mutations or dysregulation of these genes.
Announcement

Urinary

Interstitial Cystitis Association
ICA Pilot Research Program deadline: August 1 yearly
Fishbein Family IC Research Foundation deadline: March 15 yearly
The Interstitial Cystitis Association (ICA) provides and administers funding opportunities for IC research. We currently offer researchers interested in IC two programs operating on alternating cycles. Our ICA Pilot Research Program has an application deadline of August 1st each calendar year. The Fishbein Family IC Research Foundation, which the ICA administers, has an application deadline of March 15th each calendar year. Both programs foster research in the following areas of inquiry: etiology of interstitial cystitis; epidemiology of the disease; neurophysiology; serum or urine markers; potential IC treatment modalities; pregnancy and IC; and pain management. Suitable applicants will be specialists with a particular interest in IC in the areas of urology, urogynecology, or pain management.
Announcement

Violence

Faculty Development/Reentry Supplements/Traineeships/Scholarships

AAUW Educational Foundation Fellowships and Grants
American Fellowships - 2002-03 Academic Year
Postdoctoral Research Leave Fellowship: $30,000
Dissertation Fellowship: $20,000
Summer/Short-Term Research Publication Grant: $6,000
Applications available: Aug. 1-Nov. 1, 2001
Application POSTMARK deadline: Nov. 15, 2001
Fellowship year: July 1, 2002-June 30, 2003

(Applications for 2003-2004 will be available August 1, 2002)

American Fellowships support women doctoral candidates completing dissertations or scholars seeking funds for postdoctoral research leave from accredited institutions. Candidates are evaluated on the basis of scholarly excellence, teaching experience, and active commitment to helping women and girls through service in their communities, professions, or fields of research.

Postdoctoral Research Leave Fellowships offer one-year support for women who will have earned a doctoral degree by Nov. 15, 2001. In all, 20 postdoctoral fellowships are available in the arts and humanities, social sciences, and natural sciences; one is designated for a woman from an underrepresented group in any field. Limited additional funds may be available when matched by the fellow’s institution.

Dissertation Fellowships are available to women who will complete their dissertation writing between July 1, 2002, and June 30, 2003. To qualify, applicants must have completed all course work, passed all required preliminary examinations, and received approval for their research proposals or plan by Nov. 15, 2001. Students holding any fellowship for writing a dissertation in the year prior to the AAUW Educational Foundation fellowship year are not eligible. Scholars engaged in researching gender issues are encouraged to apply. Fifty-one Dissertation Fellowships are available.

Summer/Short-Term Research Publication Grants fund women college and university faculty and independent researchers to prepare research for publication. Applicants may be tenure track, part-time, temporary faculty, or independent scholars and researchers, either new or established. Time must be available for eight consecutive weeks of final writing, editing, and responding to issues raised in critical reviews. Funds cannot be used for undertaking research. Scholars with strong publishing records should seek other funding. Six publication grants are available.
Announcement